三(十八烷基)甲基溴化铵 | 18262-86-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 三(十八烷基)甲基溴化铵
• 中文别名: 甲基三十八烷基溴化铵
• 英文名称: methyltrioctadecylammonium bromide
• 英文别名: trioctadecylmethylammonium bromide；methyl(trioctadecyl)azanium;bromide
• CAS: 18262-86-7
• 化学式: Br*C₅₅H₁₁₄N
• 分子量: 869.421
• InChiKey: OPEJZUZBJHDLPL-UHFFFAOYSA-M

物化性质

• 熔点：
  89-92 °C

计算性质

• 辛醇/水分配系数(LogP)：
  17.22
• 重原子数：
  57
• 可旋转键数：
  51
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 安全说明：
  S22,S24/25
• 海关编码：
  2923900090

反应信息

• 作为反应物：
  描述：

  hydroxygallium naphthalocyaninetetrasulfonic acid 、 三(十八烷基)甲基溴化铵 以 氯仿 、 水 、 丙酮 为溶剂， 以83%的产率得到
  参考文献：
  名称：

  ALTERNATIVE PHTHALOCYANINE DYES SUITABLE FOR USE IN OFFSET INKS

  摘要：

  本发明公开了适合在溶剂基或油基油墨载体中制剂的酞菁盐。该酞菁包括一个或多个磺酸基团，至少一个磺酸基团的对离子是含有至少15个碳原子的铵阳离子。磺化镓萘酞菁的铵盐是这种酞菁盐的示例。

  公开号：

  US20090035533A1

文献信息

• PROCESS FOR PREPARING LETROZOLE
  申请人：Palle Acharyulu Venkata Raghavendra

  公开号：US20070100149A1

  公开（公告）日：2007-05-03

  A process for preparing letrozole, and purified letrozole.

  一种用于制备来曲唑和纯化来曲唑的过程。
• FLUORESCENT BRIGHTENERS, METHODS OF PREPARATION THEREOF, FLUORESCENT BRIGHTENER COMPOSITIONS, AND METHODS OF PREPARATION AND USES THEREOF
  申请人：Naik Shantaram Narayan

  公开号：US20110065843A1

  公开（公告）日：2011-03-17

  A compound of Formula (I) wherein R 1 , R 2 , and R 3 are independently at each occurrence hydrogen, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 20 aromatic functionality, with the proviso that R 2 and R 3 are not hydrogen when R 1 is a methyl or hydrogen; R 4 and R 5 are independently at each occurrence hydrogen, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 10 aromatic functionality; R 7 and R 8 are independently at each occurrence, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 10 aromatic functionality; R 6 is a C 2 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 20 aromatic functionality; and “n” and “m” are each independently integers having a value of 0 to 3.

  化合物的化学式（I），其中R1、R2和R3在每次出现时独立地为氢、卤素、氰基、C1-C20脂肪基、C3-C10环脂肪基或C3-C20芳香基，但R1为甲基或氢时，R2和R3不为氢；R4和R5在每次出现时独立地为氢、卤素、氰基、C1-C20脂肪基、C3-C10环脂肪基或C3-C10芳香基；R7和R8在每次出现时独立地为卤素、氰基、C1-C20脂肪基、C3-C10环脂肪基或C3-C10芳香基；R6为C2-C20脂肪基、C3-C10环脂肪基或C3-C20芳香基；“n”和“m”分别独立地为0至3的整数。
• Fluorescent brighteners, methods of preparation thereof, fluorescent brightener compositions, and methods of preparation and uses thereof
  申请人：Naik Narayan Shantaram

  公开号：US20070117887A1

  公开（公告）日：2007-05-24

  A compound of Formula (I) wherein R 1 , R 2 , and R 3 are independently at each occurrence hydrogen, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 20 aromatic functionality, with the proviso that R 2 and R 3 are not hydrogen when R 1 is a methyl or hydrogen; R 4 and R 5 are independently at each occurrence hydrogen, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 10 aromatic functionality; R 7 and R 8 are independently at each occurrence, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 10 aromatic functionality; R 6 is a C 2 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 20 aromatic functionality; and “n” and “m” are each independently integers having a value of 0 to 3.

  式(I)的化合物，其中R1、R2和R3在每次出现时独立地为氢、卤素、氰基、C1-C20脂肪基、C3-C10环脂肪基或C3-C20芳香基，但R1为甲基或氢时，R2和R3不为氢；R4和R5在每次出现时独立地为氢、卤素、氰基、C1-C20脂肪基、C3-C10环脂肪基或C3-C10芳香基；R7和R8在每次出现时独立地为卤素、氰基、C1-C20脂肪基、C3-C10环脂肪基或C3-C10芳香基；R6为C2-C20脂肪基、C3-C10环脂肪基或C3-C20芳香基；“n”和“m”分别独立地为0至3的整数。
• ESZOPICLONE PROCESS
  申请人：Mandava Rao Venkata Naga Brahmeswara

  公开号：US20070054914A1

  公开（公告）日：2007-03-08

  Eszopiclone is prepared by reacting zopiclone with an enatiomerically pure di-p-toluoyl tartaric acid, recovering a solid salt, and reacting a solid salt with a base. Zopiclone is prepared by reacting 6-(5-chloropyrid-2-yl)-5-hydroxy-7-oxo-5,6-dihydropyrrolo[3,4-b]-pyrazine with 1-chlorocarbonyl-4-methylpiperazine hydrochloride.

  Eszopiclone是通过将zopiclone与对映纯的二对甲苯酰酒石酸反应，回收固体盐，并将固体盐与碱反应而制备的。Zopiclone是通过将6-(5-氯吡啶-2-基)-5-羟基-7-氧代-5,6-二氢吡咯并[3,4-b]-吡嗪与1-氯羰基-4-甲基哌嗪盐酸盐反应而制备的。
• [EN] ESLICARBAZEPINE ACETATE AND ITS POLYMORPHS<br/>[FR] ACÉTATE D'ESLICARBAZÉPINE ET SES POLYMORPHES
  申请人：REDDYS LAB LTD DR

  公开号：WO2011091131A2

  公开（公告）日：2011-07-28

  Processes for the preparation of eslicarbazepine acetate and intermediates thereof. Also provided are polymorphic forms of eslicarbazepine acetate and methods for their preparation.

  制备艾司卡巴嗪乙酸酯及其中间体的过程。还提供了艾司卡巴嗪乙酸酯的多态形式及其制备方法。